For years, many patients with serious liver disease assumed they simply weren’t “eligible” for a transplant — because of their weight, how long they’d been sober, or how sick they’d become. New clinical guidance is changing that assumption.
In late 2025, the American Association for the Study of Liver Diseases (AASLD) and the American Society of Transplantation (AST) released an updated practice guideline on how adult liver transplant candidates should be evaluated. It’s still generating fresh discussion in medical circles as of September 2026 — and it meaningfully changes who should be considered for referral.
This article explains what changed, in plain language, and why it matters if you or a family member has advanced liver disease.
Related Guide
Key Findings from the Guideline
- The guideline contains 69 individual recommendations covering referral timing, medical evaluation, psychosocial assessment, and risk mitigation
- It was developed by a multidisciplinary expert group over 24 months, using a structured framework to grade the strength of evidence behind each recommendation
- The overall direction is toward earlier and more equitable referral — meaning patients should be considered for evaluation sooner, and old rigid exclusion criteria have been softened or removed
- It replaces the previous 2013 AASLD guideline, reflecting two decades of change in how transplant medicine understands risk and patient selection
How the Guideline Was Developed
- A multidisciplinary group of liver transplant specialists, along with a research librarian, reviewed the existing medical literature over a two-year period
- Each recommendation was graded using the Oxford Centre for Evidence-Based Medicine framework, which rates both the quality of evidence and the strength of the resulting recommendation
- The panel explicitly weighed the balance of risks, benefits, and patient preferences — not just clinical outcomes — when developing each statement
What Changed in the New Guidelines?
- MELD score alone is no longer a barrier to referral. MELD (Model for End-Stage Liver Disease) is a score used to estimate how urgently someone needs a transplant. The guideline states that even before a patient hits a specific MELD threshold, they should still be referred if there are signs of liver decompensation — waiting for a higher score is no longer necessary
- The “6-month sobriety rule” has been formally dropped. Previously, many transplant programs required patients with alcohol-associated liver disease to prove 6 months of sobriety before being considered. The new guideline states that length of abstinence should not be used as a reason to exclude someone from listing — especially when their liver disease is too severe to allow time to reach that milestone
- BMI is no longer a stand-alone exclusion. Body Mass Index alone can no longer be used to automatically disqualify a candidate from transplant evaluation
- Frailty is treated differently. Physical frailty is recognized as a risk factor for worse outcomes, but it is no longer, by itself, a reason to exclude someone — the guideline instead recommends using standardized frailty measurement tools for a fairer, less subjective assessment
- Very high MELD scores are not automatic disqualifiers either. Neither a MELD score above 40 nor acute-on-chronic liver failure (ACLF) is treated as a contraindication to transplant — though the medical team must still assess the overall likelihood of a good outcome
- Early referral is specifically recommended for alcohol-associated liver disease, so that psychosocial support and addiction treatment can begin before a patient’s condition worsens further
What This Means for Patients
- This is an official, published clinical guideline — not early-stage research. It’s meant to directly inform how transplant centers evaluate candidates going forward
- Patients who may have been told in the past that they didn’t qualify — due to BMI, frailty, or not meeting a sobriety timeline — may now be reasonable candidates for re-evaluation
- Good to know:
- Individual transplant centers may take time to formally update their own internal protocols to reflect these guidelines — patients should ask directly whether a center has adopted them
- “No longer a sole exclusion” does not mean these factors are ignored entirely — they are still assessed as part of a broader, individualized evaluation
- Ongoing monitoring — for alcohol use, frailty, and other risk factors — continues even after a patient is placed on the waiting list
When to Speak With a Specialist
It’s worth raising these updated guidelines directly with a liver specialist or transplant center if you or a family member:
- Has been diagnosed with decompensated cirrhosis, acute-on-chronic liver failure, or another serious liver condition
- Was previously told they weren’t eligible for transplant evaluation due to weight (BMI), frailty, or a sobriety-length requirement
- Is currently waiting to reach a certain MELD score before being referred
- Has alcohol-associated liver disease and hasn’t yet been referred for evaluation
- Wants a second opinion on their current eligibility status
Because eligibility criteria are evolving and can vary between transplant centers, getting a fresh, individualized evaluation — ideally from a specialist familiar with these updated guidelines — is the most reliable way to understand your actual options today, rather than relying on older criteria you may have been told in the past.
Related Guide
Future Research and Next Steps
- The guideline authors note this reflects the current state of evidence, and some individual recommendations are based on expert consensus where high-quality trial data is still limited
- Continued research is expected to further refine how frailty, nutrition, and psychosocial factors are measured and used in transplant decision-making
- Wider adoption across transplant centers — including consistent implementation of standardized frailty tools — remains an area to watch
Conclusion
This isn’t a guideline about a new treatment — it’s a guideline about who gets a fair chance to be considered for one. By removing rigid, one-size-fits-all exclusion criteria around BMI, sobriety length, and frailty, the updated AASLD/AST guidance opens the door for more patients to be properly evaluated for liver transplant. If you or someone you know has advanced liver disease and was previously told “not eligible,” this update may be worth revisiting with a specialist.
Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Eligibility for liver transplant is determined individually by a transplant center’s medical team.
Frequently Asked Questions (FAQs)
The updated 2025–26 AASLD/AST guideline removes several rigid exclusion criteria — including BMI as a stand-alone barrier and the 6-month sobriety rule for alcohol-associated liver disease — and recommends earlier referral, generally not waiting for a specific MELD score.
No. The updated guideline formally drops the requirement of proving 6 months of sobriety before listing, especially when the severity of liver disease doesn't allow time to reach that milestone. Ongoing monitoring is still recommended.
Yes, potentially. BMI alone is no longer treated as an automatic disqualifier under the new guideline — it's now considered as one part of a broader, individualized evaluation.
Not by itself. Frailty is recognized as a risk factor for worse outcomes, but the new guideline recommends using standardized measurement tools rather than treating frailty alone as an automatic exclusion.
The guideline recommends referral once a patient with chronic liver disease experiences a decompensating event (such as ascites, hepatic encephalopathy, or variceal bleeding), and suggests that waiting for a specific MELD score is not necessary — MELD alone should not be a barrier to referral.
Original Research Source
This article is based on findings from an updated clinical practice guideline and related medical coverage.
Primary Research: AASLD/AST Practice Guideline on Adult Liver Transplantation: Candidate Evaluation, published in Hepatology — PMC full text
Media Coverage: HCPLive — AASLD Releases New Liver Transplantation Practice Guidelines on Candidacy, Management · AASLD Official Announcement
The content has been independently rewritten, analyzed, and simplified for educational purposes to help patients and families better understand this guidance.
